Table 5.

Recommended Evaluations Following Initial Diagnosis in Symptomatic Males with Childhood Cerebral Adrenoleukodystrophy (cCALD)

System/ConcernEvaluationComment
Neurologic impairment By pediatric neurologistAssess for:
  • Specific neurologic deficits (e.g., hemiparesis, visual field defect);
  • Seizures if history is suggestive.
In presence of above, perform brain MRI if not performed at time of initial eval.
Consultation w/X-ALD comprehensive center w/experience in transplantation or ex vivo gene therapyAssess for eligibility for targeted therapy.
Behavioral issues Behavioral assessment by developmental pediatrician, primary care physicianAssess for:
  • Behaviors that may respond to medication;
  • Aggressive or disinhibited behavior.
Developmental delay/regression Developmental assessmentAssess:
  • Educational needs;
  • Need for OT service;
  • Need for PT services incl durable medical equipment.
Speech impairment By speech-language pathologistAssess for aphasia & need for alternative means of communication.
Adrenocortical insufficiency By pediatric endocrinologistScreening tests per Pediatric Endocrine Society published guidance recommendations 1
Genetic counseling By genetics professionals 2
  • To inform affected persons & their families re nature, MOI, & implications of cCALD to facilitate medical & personal decision making
  • To identify male relatives at risk for X-ALD (At-risk males may be identified by use of plasma or serum VLCFA levels or ABCD1 testing. Affected males should be evaluated as recommended in Table 4.)
Family support
& resources
Assess need for:

cCALD = childhood cerebral adrenoleukodystrophy; VLCFA = very long-chain fatty acid; X-ALD = X-linked adrenoleukodystrophy

1.
2.

Medical geneticist, certified genetic counselor, certified advanced genetic nurse

From: X-Linked Adrenoleukodystrophy

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.